Lv62
2370 积分 2023-03-12 加入
In Vitro ADME Profiling of PROTACs: Successes, Challenges, and Lessons Learned from Analysis of Clinical PROTACs from a Diverse Physicochemical Space
19小时前
待确认
AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss
1天前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
1天前
已完结
Expedited Aminoglutarimide C–N Cross-Coupling Enabled by High-Throughput Experimentation
3天前
已完结
Orally Delivered Peptides for Treatment of Inflammatory Bowel Disease
19天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
1个月前
已完结
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development
1个月前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
1个月前
已完结
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development
1个月前
已完结
Cyclic Peptide Design
1个月前
已完结
皖公网安备34019202002308
